Metraipolis › archive › dc_ba8e9855ef7d

Enhancing rare disease guideline development with real-world data: a method evaluation — Europe PMC PMID:41691167

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41691167
DOI
10.1186/s12874-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-05T19:53:36.154Z
SHA-256 of the archived text
28a6088f654f68d7e8a1f7509bb0f6020bdf42f6aeb7551730ca55b83623cd85
Stable URL of this page
https://metraipolis.com/documento/dc_ba8e9855ef7d

How to cite

Enhancing rare disease guideline development with real-world data: a method evaluation — Europe PMC PMID:41691167 — Europe PMC (en), https://europepmc.org/article/MED/41691167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba8e9855ef7d (Metraipolis archive dc_ba8e9855ef7d, sha256 28a6088f654f68d7e8a1f7509bb0f6020bdf42f6aeb7551730ca55b83623cd85)
BibTeX
@misc{dcba8e9855ef7d,
  title = {Enhancing rare disease guideline development with real-world data: a method evaluation — Europe PMC PMID:41691167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41691167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba8e9855ef7d; sha256 28a6088f654f68d7e8a1f7509bb0f6020bdf42f6aeb7551730ca55b83623cd85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41691167. Agents can read the archived copy with the MCP tool read_document.